Related Articles
Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules
Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients
Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
Identification of a novel HRAS variant and its association with papillary thyroid carcinoma